OCREVUS (ocrelizumab): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

OCREVUS 300 mg concentrate for solution for infusion

Ocrevus is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

Ocrevus is indicated for the treatment of adult patients with early primary progressive multiple sclerosis (PPMS) in terms of disease duration and level of disability, and with imaging features characteristic of inflammatory activity.


Route of administration: Injectable
Molecule: ocrelizumab

Patients' opinions on OCREVUS

In brief

General satisfaction level: 7.33/10 Learn more

Treatment's effectiveness: 7.33/10 Learn more

Ease of use: 9.33/10 Learn more

Adherence to prescription: 9.67/10 Learn more

Detected side effects: 3.67/10 Learn more

Improvement in the quality of life: 7.33/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
cwright17
on 02/05/2023

I am so happy being on this dmt! When I first started it, in June 2021, I couldn't go far without my wheelchair, but now I'm able to use just my stick when going places! It's a lot better than copaxone for me, in my opinion, and I don't know why I wasn't started on it in the first place 😞


Just wanting to add: I've not had any noticeable new lesions since I've started it.

Your message

Members using this OCREVUS

Conditions related to this medication

Fact sheet

Multiple sclerosis

See the fact sheet